Hospital
Adventhealth Polk South INC
Adventhealth Polk South INC was paid $447K by Medicaid between Jan 2018 and Sep 2020, across 77 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoADVENTHEALTH POLK SOUTH INC
LAKE WALES, FL 33853
LAKE WALES, FL 33853
33aNPI1053972760assigned 06/24/2019
33bProvider typePsychiatric Hospital Unit
28Total paid$447K
24GClaims26,653
24DCodes billed77
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other Psychiatric Hospital Unit providers in Florida
Rank by total paid#13 of 15
Median peer was paid$7.13M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,131 | $4K | |
| 2019 | 5,054 | $83K | |
| 2020 | 19,468 | $360K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 1,489 | 1,061 | $58K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 2,306 | 2,074 | $51K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 9.9% | 395 | 155 | $44K |
| G0378 | Hospital observation service, per hour | 7.4% | 223 | 121 | $33K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.1% | 541 | 504 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.4% | 356 | 324 | $24K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 542 | 454 | $20K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 1,423 | 1,207 | $18K |
| 87430 | 3.9% | 625 | 590 | $17K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 596 | 466 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.1% | 557 | 486 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 204 | 186 | $12K |
65 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 326 | $10K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 356 | $9K |
| 97597 | 2.0% | 144 | $9K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 285 | $8K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 568 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 132 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 572 | $5K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 758 | $5K |
| 84703 | 1.0% | 155 | $5K | |
| 81025 | 1.0% | 558 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 191 | $4K |
| 86756 | <1% | 113 | $4K | |
| 80306 | <1% | 219 | $4K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 31 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 249 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,216 | $3K |
| 81003 | <1% | 557 | $3K | |
| 87077 | <1% | 204 | $2K | |
| 81001 | <1% | 1,023 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 200 | $2K |
| 82962 | <1% | 420 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $2K |
| 84484 | <1% | 605 | $2K | |
| 73562 | <1% | 38 | $2K | |
| 87070 | <1% | 646 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $944.73 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 43 | $929.52 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,748 | $561.79 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | $464.88 |
| 82947 | <1% | 72 | $423.74 | |
| 74018 | <1% | 13 | $405.49 | |
| 87186 | <1% | 166 | $296.57 | |
| 73030 | <1% | 15 | $281.32 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 675 | $241.49 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 734 | $230.86 |
| 73630 | <1% | 16 | $203.41 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 382 | $179.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 480 | $115.75 |
| J2704 | Injection, propofol, 10 mg | <1% | 44 | $93.22 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 295 | $78.60 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 82 | $69.98 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $68.92 |
| 83735 | <1% | 352 | $66.45 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $64.86 |
| 94760 | <1% | 270 | $60.57 | |
| 83690 | <1% | 393 | $59.45 | |
| 87040 | <1% | 16 | $54.12 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 64 | $32.59 |
| 87088 | <1% | 134 | $27.06 | |
| 83605 | <1% | 16 | $27.06 | |
| 85379 | <1% | 89 | $20.19 | |
| 83880 | <1% | 66 | $20.19 | |
| 85610 | <1% | 230 | $16.90 | |
| 85730 | <1% | 188 | $15.64 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 407 | $13.55 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 152 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 95 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 67 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 282 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 47 | $0.00 |
| 85027 | 0% | 16 | $0.00 | |
| 82550 | 0% | 50 | $0.00 | |
| 82553 | 0% | 16 | $0.00 | |
| 76801 | 0% | 13 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENGESBACH, ALAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Adventhealth Polk North INC | Davenport, FL | $15.43M |
| Adventhealth Polk South INC | Lake Wales, FL | $7.13M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.